The price of Aprea Therapeutics Inc (NASDAQ: APRE) closed at $6.77 in the last session, down -5.05% from day before closing price of $7.13. In other words, the price has decreased by -$0.39 from its previous closing price. On the day, 1150540 shares were traded. APRE stock price reached its highest trading level at $8.09 during the session, while it also had its lowest trading level at $6.30.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Ratios:
We take a closer look at APRE’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 6.15 and its Current Ratio is at 6.15. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
On December 16, 2020, Berenberg started tracking the stock assigning a Buy rating and target price of $37.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Jun 07 ’23 when Seizinger Bernd R. bought 6,029 shares for $3.68 per share. The transaction valued at 22,192 led to the insider holds 26,325 shares of the business.
Seizinger Bernd R. bought 4,068 shares of APRE for $14,764 on Jun 06 ’23. The Director now owns 20,296 shares after completing the transaction at $3.63 per share.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, APRE now has a Market Capitalization of 26.64M and an Enterprise Value of -2.14M. For the stock, the TTM Price-to-Sale (P/S) ratio is 44.42 while its Price-to-Book (P/B) ratio in mrq is 1.25.
Stock Price History:
Over the past 52 weeks, APRE has reached a high of $8.85, while it has fallen to a 52-week low of $2.78. The 50-Day Moving Average of the stock is 6.09, while the 200-Day Moving Average is calculated to be 4.36.
Shares Statistics:
According to the various share statistics, APRE traded on average about 16.04K shares per day over the past 3-months and 13.51k shares per day over the past 10 days. A total of 3.74M shares are outstanding, with a floating share count of 3.13M. Insiders hold about 16.12% of the company’s shares, while institutions hold 24.80% stake in the company. Shares short for APRE as of Feb 15, 2024 were 79.38k with a Short Ratio of 4.95, compared to 120.26k on Jan 12, 2024. Therefore, it implies a Short% of Shares Outstanding of 2.12% and a Short% of Float of 2.52%.
Earnings Estimates
The company has 3 analysts who recommend its stock at the moment. On average, analysts expect EPS of -$0.77 for the current quarter, with a high estimate of -$0.19 and a low estimate of -$1.2, while EPS last year was -$0.92. The consensus estimate for the next quarter is -$0.2, with high estimates of -$0.2 and low estimates of -$0.2.
Analysts are recommending an EPS of between -$1.86 and -$4.27 for the fiscal current year, implying an average EPS of -$3.46. EPS for the following year is -$2.24, with 3 analysts recommending between -$0.93 and -$4.59.
